Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Cystic Fibrosis Foundation

This article was originally published in Start Up

Executive Summary

After years of battling to drum up private sector interest in a disease that afflicts only 25,000-30,000 Americans, the Cystic Fibrosis Foundation decided to take matters into its own hands. In doing so, it is charting new territory for disease-related charities. No longer content with making only small grants to academic institutions, the foundation has cut deals with biotechs that have it looking very much like a drug or biotech company itself, including significant alliances with Aurora Biosciences and Altus Biologics.
Advertisement
Advertisement

Related Content

Topics

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC090397

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel